(Q44898962)

English

Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

follicular lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

2

object named as

Delabie J

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

4

object named as

Holte H

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Gunnar Kvalheim

7

object named as

Kvalheim G

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

Blystad AK

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Kvaløy S

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Vålerhaugen H

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Ikonomou I

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

125

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

605-612

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04951.X

21 January 2018

Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04951.X

21 January 2018

Tumour cell contamination of autologous stem cells grafts in high-risk neuroblastoma: the good news?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04951.X

21 January 2018

Purging of tumor cells from leukapheresis products: experimental and clinical aspects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04951.X

21 January 2018

A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04951.X

21 January 2018

High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04951.X

21 January 2018

A new B-cell line showing a complex translocation (8;14;18) and BCL2 rearrangement

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04951.X

21 January 2018

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04951.X

21 January 2018

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04951.X

21 January 2018

Detection and relevance of minimal disease in lymphomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04951.X

21 January 2018

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04951.X

21 January 2018

Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04951.X

21 January 2018

Lymphoma cells associated with bone marrow stromal cells in culture exhibit altered growth and survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04951.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2004.04951.X

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44898962&oldid=2056188203"